20291 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
Rapamycin Derivative or an Impdh Inhibitor For Treating Polycystic Kidney Disease
#602METHODS OF TREATING JUVENILE TYPE 1 DIABETES MELLITUS
#603PHARMACEUTICAL FORMULATION
#604MITOCHONDRIALLY TARGETED ANTIOXIDANTS
#605Photosensitizer formulations for topical applications
#606Total Synthesis of Myriaporones
#607Compositions for Oral and/or Topical Administration
#608COMPOSITIONS AND METHODS FOR TREATING OBESITY AND RELATED DISORDERS
#609Protein kinase C as a target for the treatment of respiratory syncytial virus
#610Compounds and methods for promoting cellular health and treatment of cancer
#611POLYMERIC MICELLES FOR COMBINATION DRUG DELIVERY
#612Methods and systems for treating cell proliferation disorders
#613Therapeutic compositions and methods of use
#614Neurogenic compounds
#615METHODS FOR TREATMENT OF THIOL-CONTAINING COMPOUND DEFICIENT CONDITIONS
#616METHOD FOR TREATING/CONTROLLING/KILLING FUNGI AND BACTERIA ON LIVING ANIMALS
#617Therapeutic compounds and methods of use
#618METHOD FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT TRANSLOCATION
#619Deuterium Depleted Water (Ddw) Using As Adjuvant In Cancer Therapy For Cytostatics Toxicity Reducing
#620VITAMIN C PREPARATION
#621Orally-absorbed formulation for paromomycin
#622Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury
#623DRUG COMBINATIONS TO TREAT DRUG RESISTANT TUMORS
#624METHOD FOR TREATING OBESITY
#625Chromones as therapeutic agents
#626Metalloprotein inhibitors
#627Diagnosis and treatment of cancer related to human dormancy
#628Method of treating cancers using beta-lapachone or analogs or derivatives thereof
#629PHARMACEUTICAL COMPOSITION FOR REDUCING THE RISKS ASSOCIATED WITH CARDIOVASCULAR AND CEREBROVASCULAR DISEASES
#630Carnitine-Containing Peritoneal Dialysis Solution Having Improved Biocompatibility
#631COMPOSITION FOR TREATMENT OF PAIN IN BONES AND JOINTS
#632Enhanced immediate release formulations of topiramate
#633Isoflavone-containing composition
#634OCULAR DEVICES AND METHODS OF MAKING AND USING THEREOF
#635Process for treating a biological organism
#636Layered pharmaceutical formulations
#637METHODS FOR ADMINISTERING WEIGHT LOSS MEDICATIONS
#638Total Synthesis of Myriaporones
#639Combination Therapy
#640Treatment and Prevention of Heat Shock Protein-Associated Diseases and Conditions
#641Hedgehog Signaling in Prostate Regeneration Neoplasia and Metastasis
#642Application of water and organic solvent soluble Ivermectin for topical and oral use
#643Boosting immunity
#644Method of treating HIV infection
#645STATIN AND OMEGA-3 FATTY ACIDS FOR REDUCTION OF APO-B LEVELS
#646NOVEL CONTROLLED RELEASE FORMULATIONS OF DIVALPROEX SODIUM
#647CHITOSAN-COATED CALCIUM SULFATE BASED MEDICAMENT DELIVERY SYSTEM
#648Uses of selective cyclooxygenase-1 inhibitors
#649Therapy of estrogen-associated disorders
#650Medicament for treating cancer
#651METHOD FOR MODULATING THE PHARMACOKINETICS AND METABOLISM OF A THERAPEUTIC AGENT
#652Use of chromen-4-one derivatives
#653Treatment and prevention of cardiovascular disease using mast cell stabilizers
#654Litchi Sinensis Extracts Containing Oligomeric Proanthocyanidins and Processes of Making Thereof
#655Process for Effecting the Relaxation of Muscles of a Human by Means of Fragrance
#656Arginase levels/activity
#657Treatments for wound healing
#658Methods and compositions for altering mucus secretion
#659TOPICALLY APPLIED PROBUCOL-CONTAINING AGENT WITH PROTECTIVE AND REGENERATIVE EFFECT
#660CARBON-SUBSTITUTED DIKETOPIPERAZINE DELIVERY SYSTEMS
#661SCAR TREATMENT USING PROTEIN PHOSPHATASE INHIBITORS
#662Compounds and derivatives for the treatment of medical conditions by modulating hormone-sensitive lipase activity
#663Composition containing flavan compound
#664Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine
#665Cholesterol-Interacting Layered Phyllosilicates and Methods of Reducing Hypercholesteremia in a Mammal
#666Use of 8-Prenylnaringenin for Hormone Replacement Therapy
#667COMPOSITIONS FOR AFFECTING WEIGHT LOSS
#668COMPOSITIONS FOR AFFECTING WEIGHT LOSS
#669Mitochondrially targeted antioxidants
#670Methods and compositions for treatment of macular and retinal disease
#671Abnormal cannabidiols as agents for lowering intraocular pressure
#672Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
#673Modulators of CDC2-like kinases (CLKS) and methods of use thereof
#674Treatment of proliferative diseases
#675Compositions and methods of treatment using modulators of motoneuron diseases
#676Aryl aniline βadrenergic receptor agonists
#677USE OF OLIGOSACCHARIDE FOR PREVENTING BLOOD CLOTTING IN EXTRACORPOREAL BLOOD CIRCUITS
#678Histone deacetylase inhibitors for enhancing activity of antifungal agents
#679Inhibition of tissue damage to skin from radiation treatment therapy
#680Treatments for Benign Tumors, Cancers, Neoplasias, and/or Other Inflammatory Disorders or Diseases
#681Methods of cholesterol reduction using isoflavones
#682Pharmaceutical formulation
#683Compositions of a cyclooxygenase-2 selective inhibitor administered under hypothermic conditions for the treatment of ischemic mediated central nervous system disorders or injury
#684Uses of rifamycins
#685Airway Alkalinization as Therapy for Airway Diseases
#686Compositions and methods for increasing insulin sensitivity
#687Airway Alkalinization as Therapy for Airway Diseases
#688Metalloprotein inhibitors
#689METHOD OF ENHANCING MOTOR FUNCTION
#690Compositions for the treatment of affections of the oral cavity and upper respiratory tract
#691Dronabinol treatment for migraines
#692ANTI-EMETIC USES OF (3R, 4R)-DELTA8-TETRAHYDROCANNABINOL-11-OIC ACIDS
#693Use of pentadienoic acid derivatives for the treatment of hyperuricemia
#694Co-Therapy for the Treatment of Migraine Comprising Anticonvulsant Derivatives and Anti-Migraine Agents
#695HIV protease inhibitors
#696Methods of reducing the severity of mucositis
#697Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
#698Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
#699Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
#700Inducing peripheral blood vesel vasodilation
#701Stable topiramate formulations
#702Inhibitors of nitric oxide synthase to treat type 1 diabetes
#703Methods of treating overactive bladder and urinary incontinence
#704Treatment of skin, and wound repair, with thymosin beta 4
#705Compounds for modulating cell proliferation
#706Methods involving aldose reductase inhibitors
#707Compounds and methods for treating seizure disorders
#708Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia
#709Compositions suitable for the treatment of damage caused by ischemia/reper-fusion or oxidative stress
#710PEDIATRIC FORMULATION OF TOPIRAMATE
#711Combination antihistamine medication
#712C-(2-phenyl-cyclohexyl)-methylamine compounds for the treatment of anxiety disorders
#713Methods and compositions for the treatment of helicobacter pylori-associated diseases using endoperoxide bridge-containing compounds
#714Combination of tramadol and substances that comprise gabapentin
#715Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains
#716SUBSTANCE WITH SEDATIVE EFFECT
#717Mitochrondrial permeability transition pore affinity labels and modulators
#718DNA damaging agents in combination with tyrosine kinase inhibitors
#719Compositions and methods for modulating interleukin-10
#720Treatment and prophylaxis of diseases and infections pigs and poultry
#721Use of active ingredients for the prophylaxis and/or therapy of viral diseases
#722Process for effecting the relaxation of muscles of a human by means of fragrance
#723Treatment of protein degradation disorders
#724Antibacterial compounds and uses thereof
#725Combination therapy for effecting weight loss and treating obesity
#726Combination therapy for effecting weight loss and treating obesity
#727Combination therapy for effecting weight loss and treating obesity
#728Topiramate compositions for treatment of headache
#729Micro/nanoparticle obtained from lipid-containing marine organisms for use in pharmaceutics and cosmetics
#730Calcium receptor-active molecules
#731Combination antihistamine and steroid medication
#732Use of gamma- tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
#733Treatment of migraine
#734Methods and compositions involving aldose reductase
#735Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
#736Metabolic-based methods for modulating gene expression
#737ALPHA-PYRONE COMPOSITION FOR CONTROLLING CRAVING AND AS A SUBSTITUTE FOR ALCOHOL
#738Combinations for the treatment of diseases involving angiogenesis
#739Compositions and methods using same for treating amyloid-associated diseases
#740Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
#741Method of enhancing motor function
#742Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures
#743Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin II type I receptor antagonist
#744Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator
#745Compositions for down-regulation of CCR5 expression and methods of use thereof
#746Skin photoageing and actinic damage treatment
#747Repair of dna mutagenic damage
#748Controlled release preparations comprising tramadol and topiramate
#749Compositions for affecting weight loss
#750Compounds and methods for thiol-containing compound efflux and cancer treatment
#751Proteotoxin neutralizer
#752External preparation for improving blood flow
#753Deguelin as a chemopreventive agent for lung cancer
#754Novel pharmacophore for the discovery and testing of na,k-atpase inhibitor compositions and methods for their use in treating cardiovascular diseases and conditions
#755Use of equol for treating androgen mediated diseases
#756Methods and compositions for use in treating cancer
#757Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease
#758Topical application of ivermectin for the treatment of dermatological conditions/afflictions
#759Total synthesis of myriaporones
#760Pi3k antagonists as radiosensitizers
#761Composition of natural herb extract for treating cardiovascular disease and its method of preparation thereof
#762Method for the production of flavonoid-containing compositions and use thereof
#763Combination of an aromatase inhibitor with a bisphosphonate
#764Treatment of dyskinesia
#765Wortmannin analogs and methods of using same in combination with chemotherapeutic agents
#766Methods for treatment of thiol-containing compound deficient conditions
#767SUBSTITUTED 4H-CHROMENES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF
#768Compositions and methods for enhancing the effectiveness of a chemotherapeutic agent
#769Regulators of the hedgehog pathway, compositions and uses related thereto
#770Compositions and methods for selectively activating human sirtuins
#771Method for treating obesity
#772Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
#773Pharmaceutical compositions with synchronized solubilizer release
#774Therapeutic compounds and methods of use
#775Compositions comprising nebivolol
#776Synergistic gold-containing compositions
#777Novel nutraceutical compositions comprising boitin
#778Active agent transport systems
#779Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
#780Treatment of diseases involving ErbB2 kinase overexpression
#781Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
#782Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors
#783Use of deprenyl compounds to treat viral infections and reduce tissue damage associated therewith
#784Anti-constipation composition
#785Airway alkalinization as therapy for airway diseases
#786Hydrophilic polymers-flavoids conjugates and pharmaceutical compositions comprising them
#787Regulation of NAD(P)H oxidase growth and transcription in melanoma cells
#788Palatability of aquaculture feed
#789Method for treating obesity
#790Benzopyran analogs and their use for the treatment of glaucoma
#791Methods of treating a disorder
#792Method of treating acne
#793Method for identifying compounds or lead structures against rna target motifs and rna/protein interactions
#794Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto
#795Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B
#796Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule
#797Treatment of demyelinating disorders
#798Pharmaceutical composition for application to mucosa
#799Novel drug compositions and dosage forms of topiramate
#800Lapachone delivery systems, compositions and uses related thereto
#801Method and composition for the treatment of cancer
#802Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents
#803Pharmaceutical composition for preventing or treating respiratory disease
#804Fitness assay and associated methods
#805Natural cyclodextrin complexes
#806Pharmaceutical combination of artesunate and mefloquine for therapy of malaria
#807Method for treating obesity
#808Carbon-substituted diketopiperazine delivery systems
#809Method for treating obesity
#810Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders
#811Treatment of demyelinating disorders
#812Controlled release of topiramate in liquid dosage forms
#813Polyether brevetoxin derivatives as a treatment for neurotoxic shellfish poisoning and ciguatera fish poisoning
#814Use of the total coumarins of in preparation of the medicament for treating psoriasis
#815Method of treating cancers using β-lapachone or analogs or derivatives thereof
#816Compositions of a cyclooxygenase-2 selective inhibitor administered under hypothermic conditions for the treatment of ischemic mediated central nervous system disorders or injury
#817Compositions of a cyclooxygenase-2 selective inhibitor, a xanthine compound and an alcohol for the treatment of ischemic mediated central nervous system disorders or injury
#818Drug combination therapy
#819Methods of treating lower urinary tract disorders using losigamone
#820Treatments for neurogenetic disorders, impulse control disorders, and wound healing
#821Pharmaceutical compositions with synchronized solubilizer release
#822Pharmaceutical compositions with synchronized solubilizer release
#823Formulation of a mixture of Free-B-Ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
#824Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
#825Compositions of a cyclooxygenase-2 selective inhibitor and an IKK inhibitor for the treatment of ischemic mediated central nervous system disorders or injury
#826Novel drug compositions and dosage forms of topiramate
#827Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
#828Method for treating diseases using HSP90-inhibiting agents in combination with nuclear export inhibitors
#829Use of chromen-4-one derivatives
#830Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
#831Methods for treating inflammation and inflammation-associated diseases with a statin and ether
#832Bicyclic CB2 cannabinoid receptor ligands
#833Application of water and organic solvent soluble ivermectin for topical and oral use
#834Treatment of protein degradation disorders
#835Combination therapy for treating cancer
#836Method for transnasal delivery of anticonvulsant and therapeutic treatments
#837Method for cancer cell reprogramming
#838Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts